Company Filing History:
Years Active: 2015-2019
Title: Innovations by Inventor Jianghui Meng in Therapeutics for Chronic Pain
Introduction
Jianghui Meng is an accomplished inventor based in Dublin, Ireland, known for his significant contributions to the field of therapeutics. With a total of three patents to his name, his work focuses particularly on addressing chronic pain and related inflammatory disorders.
Latest Patents
One of Jianghui Meng's most innovative contributions is his patent on multiprotease therapeutics for chronic pain. This invention involves Clostridial neurotoxin derivatives that contain at least two light chain endopeptidase domains, along with nucleic acids encoding such derivatives. In preferred embodiments, the patent outlines methods and compositions aimed at treating inflammatory disorders, including arthritis, and various forms of chronic pain, such as neuropathic pain and inflammatory pain. Specifically, it features Clostridial neurotoxin derivatives that are derived from an intact BoNT/A, which has an LC/E-derived endopeptidase linked to the LC/A endopeptidase.
Career Highlights
Jianghui Meng's work is part of his professional journey at Dublin City University, where he has made notable advancements in the understanding and treatment of chronic pain. His innovative spirit and research focus have positioned him as a leading figure in his field.
Collaborations
Throughout his career, Jianghui has collaborated with esteemed colleagues such as James Oliver Dolly and Jiafu Wang. These partnerships have enhanced the depth of research and development in the therapeutics landscape, driving forward the potential for new treatment modalities.
Conclusion
In summary, Jianghui Meng stands out in the realm of innovation through his research and inventive approaches to chronic pain therapy. His patents highlight significant advancements in the use of neurotoxin derivatives, emphasizing his role in paving the way for future therapeutic options. As a committed inventor, his contributions continue to influence the landscape of pain management and inflammatory disorder treatments.